Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Takeda IP Holdings Co., Ltd. (7875:JPX), powered by AI.
Takeda IP Holdings Co., Ltd. is currently trading at ¥740. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Takeda IP Holdings Co., Ltd. on Alpha Lenz.
Takeda IP Holdings Co., Ltd.'s P/E ratio is 4929.2.
“Takeda IP Holdings Co., Ltd. trades at a P/E of 4929.2 (premium valuation) with modest ROE of 7.0%.”
Ask for details →Takeda IP Holdings Co., Ltd. is a predominant player in the pharmaceutical and biotechnology industries, focusing on the management and commercialization of intellectual property assets. The company’s primary function is to leverage its extensive portfolio of patents and technology innovations to drive advancements in medical treatments and drug development. This strategic approach includes partnerships with research institutions and licensing arrangements with global pharmaceutical companies, enabling the commercialization of groundbreaking therapeutics. Takeda IP Holdings plays a crucial role in the healthcare sector by facilitating the transfer and application of critical technologies that address unmet medical needs. Through its operations, the company contributes significantly to the enhancement of healthcare outcomes, standing as a key entity in the synthesis of research and industrial application within the biomedical field.
“Takeda IP Holdings Co., Ltd. trades at a P/E of 4929.2 (premium valuation) with modest ROE of 7.0%.”
Ask for details →Takeda IP Holdings Co., Ltd. (ticker: 7875) is a company listed on JPX in the Communication Services sector (Publishing). It has approximately 901 employees. Market cap is $6.2T.
The current price is 740 with a P/E ratio of 4,929.18x and P/B of 337.96x.
ROE is 7.04% and operating margin is 4.04%. Annual revenue is $34.2B.